Menu

Genetic Testing Firm 23andMe Files For Bankruptcy: What Does This Mean For Me?

On 23 March 2025 came news that genetic testing firm 23andMe has filed for bankruptcy following financial difficulties and concerns about data privacy. 23andMe started in 2006 and went public in 2021. However, it never made a profit. It struggled to convert customers who purchased its core product, an at-home DNA testing kit, into subscribers offering personalised feedback and wellness plans. In 2023, 23andMe was hacked affecting the personal data of 7 million users, resulting in a reported $30 million settlement bill. Then in 2024, it let go of forty percent of its workforce and stopped the development of its research and development programmes. Its recent decision to file for bankruptcy is aimed at procuring a sale. However, it leaves its 15 million users around the world questioning what will happen to their genetic data?
Read More

Ethica Fertility Launch Event

Louisa Ghevaert had the pleasure of celebrating the Ethica Fertility launch event on 20 March 2025 at Barnby Street in London with other dedicated professionals in the fertility and family building space. Ethica Fertility's mission is to offer an innovative, more personalised approach to fertility care and reproductive health. Louisa was delighted to meet the team at Ethica Fertility, take a tour of their state of the art clinic facilities and learn more about their holistic approach to assisted conception and patient centric care. Ethica Fertility seeks to redefine fertility care and make fertility care more inclusive, effective and supportive, leading to better outcomes for patients no matter their race, gender, sexual orientation or family structure.
Read More

Epigenetics In Human Reproduction

Louisa Ghevaert was delighted to attend the Nuffield Council on Bioethics workshop “Epigenetics in human reproduction” in central London on 11 March 2025. This event looked at the use and implications of epigenetics in human reproduction. It considered the inter-relationships between the reproductive environment, the epigenome, long-term health and assisted reproductive technologies. It went on to explore current and future scientific applications, ethical, legal and social implications. In doing so, it explored all sorts of important and complex questions and issues. How do you measure or control the environment? How effective may an intervention be and at what stage to optimise health, pregnancy and birth? How do you account for epigenetic responses (mechanisms that regulate gene expression without changing the DNA sequence) that differ between people? How reliable is epigenetic testing? How can you provide effective messaging? How do you address these issues from a policy perspective?
Read More

Lessons To Be Learned By The Fertility Sector From the Infected Blood Scandal & Inquiry

Louisa Ghevaert was pleased to attend a Progress Educational Trust Event on 26 February 2025 "What Can The Fertility Sector Learn From The Infected Blood Scandal And Inquiry?". The Contaminated Blood Scandal was one of the worst health scandals in the UK from the 1970s - 1990s, resulting in thousands of deaths from infected blood transfusions and blood products. This event looked at the similarities between fertility (eggs, sperm and embryos) and blood, the findings of the Infected Blood Inquiry in the UK and the lessons to be learned across the fertility sector to ensure optimum patient safety and care. Given rapid advances in reproductive medicine and growing demand fro fertility treatment, it is more important than ever to maximise reproductive choice, optimise care and protections and make informed decisions about pathways to parenthood.
Read More

In the News

Father and toddler

X updates

Follow Louisa on X for latest industry updates

Read More

Our latest news

Read our news on fertility & modern family law

Read More

Our blog

Louisa discusses her opinion on different topics

Read More